Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15 , 1068

Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15 , 1068

The following paragraph, "Coinciding but insignificant findings with regards to the time to negative PCR were established by Pott-Junior et al [...].The following paragraph, "Coinciding but insignificant findings with regards to the time to negative PCR were established by Pott-Junior et a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceuticals (Basel, Switzerland) Switzerland), 2024-08, Vol.17 (8), p.1100
Hauptverfasser: Awad, Hoda, Hassan, Basmala, Dweek, Sara, Aboelata, Yasmeen, Rawas-Qalaji, Mutasem, Ahmed, Iman Saad
Format: Artikel
Sprache:eng
Schlagworte:
Antiparasitic agents
COVID-19
Disease prevention
n/a
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The following paragraph, "Coinciding but insignificant findings with regards to the time to negative PCR were established by Pott-Junior et al [...].The following paragraph, "Coinciding but insignificant findings with regards to the time to negative PCR were established by Pott-Junior et al [...].
ISSN:1424-8247
1424-8247
DOI:10.3390/ph17081100